|
Showing 1 - 4 of
4 matches in All Departments
This volume attemptsto provide the formulation scientist with
casehistories involving the use of therapeutic proteins and
peptides that have been mar- keted or are under clinical testing.
In previous volumes of this series,funda- mental theories and
principles ofprotein characterization and stability were presented
in depth by researchers in their fieldsofexpertise. The way from
theory to practice isnot alwaysobvious and straightforward. There
isa need for practical examples of how the principles and theories
are put into use, specificallyin the development of a
pharmaceutical product. It is our hope that this volume will
fulfillsuch a need. Itisnot asimple task to choose a panel
ofproteinsand peptides from the over 200 agents in human clinical
trials. We have tried to collect a wide representation of molecules
of different sizes-from 10 amino acids (Leu- prolide) to 1020 amino
acids (Muromonab CD3). The examples include agents derived from
various sources including monoclonal antibodies (Mur- omonab CD3),
recombinant DNA (human and bovine growth hormones), natural source
(fibrolase), and chemical synthesis (Leuprolide). Clearly this list
is not intended to be encyclopedic. It isthe first time a
collection of this sort has been made accessibleto the formulation
scientists involved in devel- oping protein and peptide products.
Although each chapter in this volume focuses primarily on the
charac- terization and stability of a specific molecule, each has
unique aspects.
Leading scientists offer detailed profiles of ten protein drugs
currently in development. The case histories of these important new
compounds are described from the perspective of their formulation,
characterization, and stability. This ready reference also features
recent data and an abundance of previously unpublished information.
The in-depth coverage includes a highly useful compendium of
degradation sites occurring in over 70 proteins. An invaluable aid
in the rapid identification of potential 'hot spots' in proteins,
this accessible compilation allows for inspection of the protein's
primary structure and preparation of a hydroflex plot.
Leading scientists offer detailed profiles of ten protein drugs
currently in development. The case histories of these important new
compounds are described from the perspective of their formulation,
characterization, and stability. This ready reference also features
recent data and an abundance of previously unpublished information.
The in-depth coverage includes a highly useful compendium of
degradation sites occurring in over 70 proteins. An invaluable aid
in the rapid identification of potential hot spots' in proteins,
this accessible compilation allows for inspection of the protein's
primary structure and preparation of a hydroflex plot.
This volume attemptsto provide the formulation scientist with
casehistories involving the use of therapeutic proteins and
peptides that have been mar- keted or are under clinical testing.
In previous volumes of this series,funda- mental theories and
principles ofprotein characterization and stability were presented
in depth by researchers in their fieldsofexpertise. The way from
theory to practice isnot alwaysobvious and straightforward. There
isa need for practical examples of how the principles and theories
are put into use, specificallyin the development of a
pharmaceutical product. It is our hope that this volume will
fulfillsuch a need. Itisnot asimple task to choose a panel
ofproteinsand peptides from the over 200 agents in human clinical
trials. We have tried to collect a wide representation of molecules
of different sizes-from 10 amino acids (Leu- prolide) to 1020 amino
acids (Muromonab CD3). The examples include agents derived from
various sources including monoclonal antibodies (Mur- omonab CD3),
recombinant DNA (human and bovine growth hormones), natural source
(fibrolase), and chemical synthesis (Leuprolide). Clearly this list
is not intended to be encyclopedic. It isthe first time a
collection of this sort has been made accessibleto the formulation
scientists involved in devel- oping protein and peptide products.
Although each chapter in this volume focuses primarily on the
charac- terization and stability of a specific molecule, each has
unique aspects.
|
You may like...
Easy Al Fresco
Ilse van der Merwe
Paperback
R430
R336
Discovery Miles 3 360
|